| Target Price | HK$68.18 |
| Price | HK$36.28 |
| Potential |
87.93%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target JD Health International 2027 .
The average JD Health International target price is HK$68.18.
This is
87.93%
register free of charge
HK$97.75
169.44%
register free of charge
HK$50.10
38.08%
register free of charge
|
|
| A rating was issued by 23 analysts: 20 Analysts recommend JD Health International to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the JD Health International stock has an average upside potential 2027 of
87.93%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 86.00 | 102.69 |
| 26.28% | 19.41% | |
| EBITDA Margin | 6.99% | 6.80% |
| 17.47% | 2.71% | |
| Net Margin | 7.32% | 8.01% |
| 2.28% | 9.44% |
18 Analysts have issued a sales forecast JD Health International 2026 . The average JD Health International sales estimate is
This results in the following potential growth metrics:
19 JD Health International Analysts have issued a net profit forecast 2026. The average JD Health International net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 1.97 | 2.56 |
| 27.92% | 29.95% | |
| P/E | 14.16 | |
| EV/Sales | 0.53 |
19 Analysts have issued a JD Health International forecast for earnings per share. The average JD Health International EPS is
This results in the following potential growth metrics and future valuations:
JD Health International...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


